Pituitary function was assessed before and after transsphenoidal hypophysectomy in 39 dogs with pituitarydependent hyperadrenocorticism (PDH). Anterior pituitary function was investigated using combined administration of four hypophysiotropic releasing hormones (corticotropin-releasing hormone (CRH), GHRH, GnRH, and TRH) with measurements of ACTH, cortisol, GH, LH, prolactin (PRL), and TSH. Pars intermedia function was assessed by measurements of basal plasma -MSH concentrations and adrenocortical function by baseline urinary corticoid/creatinine ratios.
Introduction
Since the late 1980s there has been consensus with regard to the therapy of Cushing's disease. Transsphenoidal pituitary microsurgery is considered the primary treatment (Melby 1988 , Thorner et al. 1992 , despite a rate of recurrence of 20-30% (McCance et al. 1993 , Sonino et al. 1996 . In order to minimize the consequences of recurrences, parameters have been identified that might predict the risk of recurrence at an early stage. Adrenocorticotropic hormone (ACTH) hyperresponsiveness to an early postoperative stimulation with corticotropin-releasing hormone (CRH) seems to be a valuable criterion of recurrence (Vignati et al. 1994) , although early postoperative measurements of plasma and/or urinary cortisol may safely replace tests using supra-pituitary stimulants (Pieters et al. 1989 , de Lange & Sluiter 1993 , Toms et al. 1993 , Trainer et al. 1993 , McCance et al. 1996 ).
In the debate over possible ways to decrease the number of recurrences and over the early detection of surgical failure, corticotropic cell hyperplasia has played a confounding role. It was presumed to be due to excessive production of hypothalamic CRH but in recent years it has been demonstrated that CRH concentrations in cerebrospinal fluid of both humans (Kling et al. 1991) and dogs (van Wijk et al. 1992 ) with pituitary-dependent hyperadrenocorticism (PDH) are lower than in healthy individuals. Moreover, there is now increasing evidence that the disease originates at the pituitary level by clonal expansion of a single aberrant cell (Pei & Melmed 1996) and that corticotropic hyperplasia does not exist in Cushing's disease (Trouillas et al. 1996) .
Studies are therefore now directed at the biological basis of recurrence, i.e., at the proliferation potential of different pituitary cells and of adenoma cells (Laws et al. 1996) . In this respect our recent reports on the development of a combined anterior pituitary test are of interest (Meij et al. 1996a,b) . After hypophysectomy in healthy dogs, residual corticotropic cells were much more prone to respond in the combined anterior pituitary function test than were other types of anterior lobe cells (Meij et al. 1997a) .
Under the assumption that this distinct behaviour of remnant corticotropic cells might play a role in the development of recurrent hyperadrenocorticism, we have now characterized pituitary function before and after hypophysectomy in dogs with PDH, a condition which has many similarities with Cushing's disease in humans (Kemppainen & Peterson 1994 ).
Materials and Methods

Animals and treatment
The group of dogs with PDH (n=39; median age 10 years; range 6-14 years) comprised 22 females (14 ovariohysterectomized) and 17 males (5 castrated). The diagnosis of hyperadrenocorticism was based upon the characteristic signs and symptoms, such as polyuria, skin atropy, and increased abdominal size (Rijnberk et al. 1968) , and upon elevated urinary corticoid/creatinine ratios in two consecutive morning urine samples (Stolp et al. 1983 , Rijnberk et al. 1988a . Immediately after collection of the second urine sample, the animals received three oral doses of 0·1 mg dexamethasone/kg body weight at 8-h intervals. The next morning, a third urine sample was collected. When the ratio in the third sample was less than 50% of the mean in the first two samples, the dog was categorized as being responsive to dexamethasone suppression and PDH was diagnosed. In eight dogs in which there was less than 50% suppression of the corticoid/creatinine ratio, i.e. the dexamethasone-resistant animals, the diagnosis of PDH was secured by at least five measurements of basal plasma ACTH (Rijnberk et al. 1987) , visualization of the adrenals by ultrasonography (Voorhout et al. 1990) , and imaging of the pituitary gland by computed tomography (Voorhout 1990 , Meij et al. 1997b . In all 39 dogs the baseline urinary corticoid/creatinine ratios exceeded the upper limit of the reference range (10 10 6 ) and ranged from 11 to 275 10 6 (median 56 10 6 ). In all 39 dogs plasma ACTH values (d50 ng/l) were consistent with PDH and ranged from 51·0 to 606·7 ng/l (median 159·3 ng/l).
Transsphenoidal hypophysectomy was performed according to a microsurgical technique described previously (Meij et al. 1997b) . Immediately following removal of the pituitary gland, treatment was started with 1 mg hydrocortisone (Solu-Cortef; Upjohn, Ede, The Netherlands)/kg every 6 h (i.v.), and 0·01% desmopressin (Minrin; Ferring, Hoofddorp, The Netherlands), 1 drop every 8 h in the conjunctival sac. Drinking was allowed as soon as the dog was awake. When the dog had resumed drinking and eating, oral substitution therapy was started by administering 2 mg cortisone acetate (Cortisoni acetas; Genfarma, Maarssen, The Netherlands)/kg every 12 h and 10 µg thyroxine (-thyroxine; Aesculaap, Boxtel, The Netherlands)/kg every 12 h, and the animals were discharged from the clinic. At home the dose of cortisone acetate was gradually lowered over a period of 4 weeks to 0·25-0·5 mg/kg every 12 h. Desmopressin was discontinued after 2-4 weeks. Daily water intake was measured by the owner for at least 4 weeks after surgery.
Stimulation test
After an overnight fast, the test was performed between 0800 and 1200 h. Anterior pituitary function was investigated before and at a median period of 8 weeks (range 6-18 weeks) after surgery by rapid sequential i.v. administration of four hypothalamic releasing hormones, as described previously (Meij et al. 1996a,b) . Ovine CRH (Peninsula Laboratories, Belmont, CA, USA) and human growth hormone-releasing hormone (hGHRH; Peninsula Laboratories) were both stored frozen at 25 C, and thawed at room temperature immediately before use. The gonadotropin-releasing hormone (GnRH) analogue, gonadorelin (Fertagyl; Intervet, Boxmeer, The Netherlands) and thyrotropin-releasing hormone (TRH; Hoffman-La Roche, Basel, Switzerland) were stored at 4 C.
An i.v. catheter was placed in the cephalic vein of each dog to facilitate rapid sequential injections. The four releasing hormones were injected i.v. within 30 s, immediately following the collection of the zero blood sample from the jugular vein. The releasing hormones were injected in the following order and doses: 1 µg CRH/kg, 1 µg GHRH/kg, 10 µg GnRH/kg, and 10 µg TRH/kg. The clock for blood sampling times was started immediately after the administration of the last releasing hormone. Blood samples were collected by jugular vein puncture at 30, 15, 0, 5, 10, 20, 30, 45, 60, 90 , and 120 min (-15 to 45 min for plasma thyrotropin (TSH)) after injection and were placed in ice-chilled EDTA-coated plastic tubes. The samples were centrifuged at 4 C for 10 min and plasma was stored at 25 C until assayed for cortisol, ACTH, growth hormone (GH), luteinizing hormone (LH), prolactin (PRL), and TSH. Before and after surgery pars intermedia function was assessed by measurements of plasma -melanotropin ( -MSH) in the 30, 15, and 0 min samples of the anterior pituitary function test.
Measurements of post-surgical corticoid/creatinine ratios in two consecutive morning urine samples were performed just prior to the anterior pituitary function test and at variable intervals thereafter. Each urine sample after surgery was collected after oral cortisone had been omitted for 24 h. Remission of PDH was defined as full remission of signs of hyperadrenocorticism and urinary corticoid/creatinine ratios <10 10 6 .
Hormone determination
Adrenocorticotropic hormone was measured by RIA without extraction according to methods described previously (Arts et al. 1985 , Rijnberk et al. 1988b . Antiserum was obtained from IgG Corporation (Nashville, TN, USA). The tracer was purchased from International CIS (St Quentin-Yvelines, France) and the standard was obtained from the National Institutes of Health (Bethesda, MD, USA). The intra-assay and interassay coefficients of variation were 8% and 12% respectively, and the detection limit was 10 ng/l.
Cortisol was measured by RIA (Rijnberk et al. 1988a,b) . The detection limit for cortisol was 1 nmol/l and the intra-assay and interassay coefficients of variation were 6% and 8% respectively.
Growth hormone was measured in an homologous RIA as described previously (Eigenmann & Eigenmann 1981) . The intra-and interassay coefficients of variation were 3·8 and 7·2% respectively, and the sensitivity of the assay was 0·4 µg/l plasma. The degree of cross-reaction of canine prolactin was 2%.
Plasma LH was measured in an heterologous RIA (Nett et al. 1975) . A rabbit antiserum raised against ovine LH (CSU-204), radioiodinated NIAMDD-bLH-4, and canine pituitary standard LER 1685-1 were used in this assay. The detection limit for LH was 0·31 µg/l and the intra-assay and interassay coefficients of variation were 2·3% and 10·5% respectively. Plasma PRL was measured in an heterologous RIA (Stolp et al. 1986 ). The detection limit was 0·8 µg/l plasma and the intra-assay and interassay coefficients of variation were 3·5% and 11·8% respectively. The degree of cross-reaction of canine GH was 0·08%.
Plasma TSH was measured by immunoradiometric assay (IRMA) using a commercially available kit (Diagnostic Products Company, Los Angeles, CA, USA) (Williams et al. 1996) . The sensitivity of the assay was 0·03 µg TSH/l. The intra-and interassay variation coefficients were 2·4 and 3·9% respectively, at mean TSH concentrations of 4·6 and 3·6 µg/l. There was negligible crossreactivity of canine LH or follicle-stimulating hormone in the assay for canine TSH.
Plasma -MSH was measured by RIA using antiserum to synthetic human -MSH (Rijnberk et al. 1988b ). This antiserum reacted equally with -MSH and desacetyl--MSH. Synthetic human -MSH was used as a standard. The detection limit was 10 ng/l and the intra-assay and interassay coefficients of variation were 10% and 23% respectively. A plasma -MSH concentration above 60 ng/l was considered to be elevated (Rijnberk et al. 1988b) .
Statistical analysis
Results are presented as means ... Mean basal levels were calculated from the 30, 15, and 0 min values (ACTH, cortisol, GH, LH, PRL, and -MSH) and the 15 and 0 min values (TSH) in the stimulation test. In the stimulation tests increments of plasma concentrations were calculated as the difference between peak levels and mean basal levels. The areas under the curve (AUC) of the hormone concentrations in the stimulation tests were calculated by the trapezoidal method after subtraction of the mean basal level. Differences between pre-operative and postoperative basal levels, increments, and AUC for all dogs (n=39) were analyzed by Student's t-test for paired samples. Differences in hormone variables between the dogs with urinary corticoid/creatinine ratios c5 10 6 (n=35) and dogs with ratios >10 10 6 (n=4) at 8 weeks after surgery were analyzed by Student's t-test for independent samples. Differences in basal levels and responses for LH between noncastrated dogs (n=20) and castrated dogs (n=19) were analyzed by Student's t-test for independent samples. Pearson's correlation coefficients (twotailed) were calculated between urinary corticoid/ creatinine ratios and basal values and responses after stimulation for both plasma ACTH and cortisol. Correlations were also calculated between the corticotropic (ACTH and cortisol) variables and other hormone (GH, LH, PRL, TSH, and -MSH) variables. Differences in median urinary corticoid/creatinine ratios at 8 weeks, and at 16 and 22 months after hypophysectomy were analyzed by the nonparametric Wilcoxon matched-pairs signedranks test. P<0·05 was considered significant.
Results
Basal plasma levels for ACTH, cortisol, GH, LH, PRL, and TSH were significantly lower at 8 weeks after hypophysectomy than before surgery (Table 1, Fig. 1 ). No side effects were observed after the combined administration of releasing hormones in the dogs with PDH, either before or after hypophysectomy. Before hypophysectomy, hypophysiotropic stimulation caused prompt increases in plasma ACTH, cortisol, GH, LH, PRL, and TSH in all 39 dogs (Fig. 1) . The peak plasma ACTH, cortisol, GH, LH, PRL, and TSH concentrations were (mean ...): ACTH, 469·9 61·6 ng/l at 5 min (Fig. 1a) ; cortisol, 808·1 64·2 nmol/l at 20 min (Fig. 1b) ; GH, 5·0 1·0 µg/l at 20 min (Fig. 1c) ; LH, 41·0 4·3 µg/ l at 10 min (Fig. 1d) ; PRL, 124·4 20·4 µg/l at 5 min (Fig. 1e) ; TSH, 0·59 0·05 µg/l at 20 min (Fig. 1f ) . At 8 weeks after hypophysectomy there were no plasma GH, LH, PRL, and TSH responses to stimulation (increments and AUC approximately zero), whereas plasma ACTH and cortisol responses were small but significant (Table 1 , Fig. 1 ). After hypophysectomy the maximum plasma ACTH, cortisol, GH, LH, PRL, and TSH concentrations were (mean ...): ACTH, 140·6 17·9 ng/l at 10 min (Fig. 1a) ; cortisol, 249·6 30·0 nmol/l at 10 min (Fig. 1b) ; GH, 0·9 0·0 µg/l at 5 min (Fig. 1c) ; LH, 4·7 0·6 µg/l at 5 min (Fig. 1d) ; PRL 6·8 1·4 µg/l at 5 min (Fig. 1e) ; TSH, 0·03 0·00 µg/l (Fig. 1f ) .
In 35 dogs, in which remission of signs of hyperadrenocorticism had occurred at 8 weeks after surgery, urinary corticoid/creatinine ratios ranged from 0·2 10 6 to 5·0 10 6 (median 1·5 10 6 ) ( Fig. 2 ). There were 16 dogs with urinary corticoid/creatinine ratios c1 10 6 and 19 dogs with ratios >1 and c5 10 6 . In the majority of the 35 dogs, there were still significant residual plasma ACTH and cortisol responses after hypophysectomy. Only one dog had no plasma ACTH response after hypophysectomy (increment=0) and five dogs had increments <10 ng/l. In 23 of these 35 dogs no remnants of pituitary tissue were identified with computed tomography (CT) at the time of pituitary function testing, in 10 dogs small localized areas of contrast enhancement were observed and in 2 dogs CT was not performed.
Signs of hyperadrenocorticism had not disappeared after surgery in 4 dogs with urinary corticoid/creatinine ratios of 21, 34, 82, and 138 10 6 at 8 weeks after hypophysectomy (Fig. 2) . Repetition of CT in these dogs revealed considerable pituitary tumor remnants, confirming that hypophysectomy had been incomplete. Plasma ACTH and cortisol responses (increments and AUC) after stimulation in these 4 dogs were significantly higher than in the 35 dogs that were free of signs of hyperadrenocorticism.
Before hypophysectomy there were no significant correlations between the baseline urinary corticoid/ creatinine ratios and basal values or responses for both plasma ACTH (Fig. 2) and cortisol. In the 35 dogs which were free of signs of hyperadrenocorticism at 8 weeks after hypophysectomy, there were significant correlations between urinary corticoid/creatine ratios on the one hand and basal plasma ACTH values (r=0·66, P<0·005) (Fig. 2a) , plasma ACTH peak values (r=0·39, P<0·05) (Fig. 2b) , basal plasma cortisol values (r=0·51, P<0·005), and plasma cortisol peak values (r=0·56, P<0·0005) on the other. After surgery, there were no significant correlations between the corticotropic (ACTH and cortisol) variables (basal levels and responses) and the other pituitary hormone (GH, LH, TSH, and -MSH) variables, except for PRL. Although there was no significant plasma PRL response at 8 weeks after surgery (Table 1, Fig. 1e ), there was a significant correlation (n=35) between ACTH and PRL basal levels (r=0·48, P<0·005).
In three dogs (nos. 13, 21, and 25) remission of hyperadrenocorticism was initially achieved with corticoid/creatinine ratios of 0·3, 3·5, and 0·6 10 6 respectively, at 8 weeks after hypophysectomy. However, at respectively 11, 7, and 16 months postoperatively, signs of hyperadrenocorticism recurred and the ratios had increased to values >10 10 6 (32, 31·5, and 26 10 6 respectively). In dog no. 13 localized areas of contrast enhancement in the pituitary fossa were identified by CT at 8 weeks after hypophysectomy, indicating the presence of pituitary remnants. In the other two dogs (nos. 21 and 25) contrast-enhanced CT revealed no remnant pituitary tissue. At 8 weeks after hypophysectomy in the latter two dogs (nos. 21 and 25) there were plasma ACTH increments to stimulation of 18·3 and 195 ng/l respectively. In dog no. 13 the combined anterior pituitary function test was repeated 1 month after recurrence of signs of hyperadrenocorticism, i.e. 12 months postoperatively. Prior to surgery, and at 2 and 12 months after hypophysectomy, basal plasma ACTH concentrations in dog no. 13 were The releasing hormones were injected in the following order and doses: 1 g CRH/kg body weight (bw), 1 µg GHRH/kg bw, 10 g GnRH/kg bw, and 10 g TRH/kg bw. Basal levels and increments in plasma ACTH, cortisol, GH, LH, PRL and TSH were significantly lower after hypophysectomy (Student's t-test, P<0·05).
164·3 ng/l, 17·3 ng/l, and 153·7 ng/l respectively; the corresponding plasma ACTH increments at the same times were 98·7 ng/l, 37·7 ng/l, and 863·3 ng/l respectively. CT repeated in dog no. 13 at 1 month after recurrence, i.e. 12 months postoperatively, showed that the localized areas of contrast enhancement in the pituitary fossa had increased in size compared with the CT image at 8 weeks after hypophysectomy. In 32 dogs, hyperadrenocorticism remained in remission for a median follow-up period of 22 months (range 2 to 42 months) and urinary corticoid/creatinine ratios ranged from 0·1 to 5·9 10 6 (median 2·0 10 6 ). At that time urinary corticoid/creatinine ratios were c1 10 6 in 9 dogs and >1 and c5 10 6 in 22 dogs, whereas in one dog the urinary corticoid/creatinine ratio varied between 5 and 10 10 6 . In the dogs in which hyperadrenocorticism remained in remission there were no differences in median urinary corticoid/creatinine ratios at 8 weeks (1·5 10 , 32 dogs) after hypophysectomy (Wilcoxon matched-pairs signed-ranks test, P<0·05). In 2 dogs (nos. 1 and 5) that died of unrelated causes while in remission at respectively 5 and 2 months postoperatively, microscopic examination of the sella revealed islets of nontumorous adenohypophyseal tissue embedded in fibrous tissue.
Prior to surgery there were seven dogs with elevated basal plasma -MSH values (352·7 105·4 ng/l). In the other 32 dogs the values (21·8 2·1 ng/l) were not elevated (Fig. 3) . In the group of seven dogs plasma -MSH concentrations were significantly lower after hypophysectomy (19·5 2·2 ng/l) compared with preoperative values, and not significantly different from plasma -MSH concentrations in the group of 32 dogs, either before or after hypophysectomy (20·3 2·9 ng/l) (Fig. 3) .
Discussion
Complete hypophysectomy should result in very low urinary corticoid/creatinine ratios. In the present study we defined remission by the complete disappearance of signs of hyperadrenocorticism together with urinary corticoid/ creatinine ratios below the upper limit of the reference range, that is <10 10 6 (Rijnberk et al. 1988a ). Measurable urinary corticoid/creatinine ratios <5 10 6 at 8 weeks after surgery in 35 dogs, although the dogs were in remission, suggested that there was some residual function of the pituitary-adrenocortical axis. This was confirmed by the ACTH and cortisol responses in the combined anterior pituitary function test in almost all dogs.
In the combined anterior pituitary function test performed at 8 weeks after hypophysectomy, there were Figure 2 Relation between baseline urinary corticoid/creatinine (C/C) ratios and (a) basal plasma ACTH concentrations, and (b) the plasma ACTH peak concentrations after stimulation with a combination of four hypothalamic releasing hormones (see also legend to Fig. 1 ), in 39 dogs with PDH before () and at 8 weeks after () transsphenoidal hypophysectomy (HX). After HX, Pearson's correlation coefficient was (a) 0·66 (P<0·005), and (b) 0·39 (P<0·05). The dogs with C/C ratios >10 10 6 (dashed line) had signs of hyperadrenocorticism. no plasma GH, LH, PRL, or TSH responses to hypophysiotropic stimulation, whereas plasma ACTH and cortisol responses were small but significant. The corticotropic response to stimulation after hypophysectomy is highly suggestive of residual function by small islets of pituitary cells in the sella turcica containing corticotropic cells, as observed in a previous study in healthy beagle dogs (Meij et al. 1997a) . After surgery, in contrast to before, urinary corticoid/creatinine ratios and basal and stimulated plasma ACTH levels in the hyperadrenocorticoid dogs were positively correlated, indicating restoration of the normal regulatory mechanisms.
Thus, we have here the intriguing observation in both healthy dogs and dogs with PDH that of the few remnant cells in the sella, only the corticotropic cells tend to be functional. As it was found not only in the dogs with PDH but also in the healthy dogs, the phenomenon cannot be ascribed to persistent tumor. In addition, after hypophysectomy in the dogs with PDH, the restoration of normal regulation, the low urinary corticoid/creatinine ratios, the long-term remission, and the finding of only normal pituitary tissue in the sella of two dogs in remission that died of unrelated disease, argue against adenoma tissue being the cause of the ACTH release after hypophysectomy. Three possible explanations will be presented for this remnant nontumorous ACTH secretion following hypophysectomy. One is related to the decreased inhibitory effect of glucocorticoids. The second and the third deal with the possibility that the sellar fragments are devoid of either hypophysiotropic inhibitory influences or inhibitory paracrine influences.
First, structural changes in pituitary corticotropes are known to correlate with changes in the physiological state of the animal (Childs 1992) . For example, in rats both the number and the structure of corticotropes change after adrenalectomy or chronic stimulation with CRH. Secretatogues like CRH or arginine vasopressin (AVP) increase the percentages of corticotropes that bind CRH and store ACTH which has led to the idea of the existence of reserve cells that may be sensitive to certain levels or types of stimuli (Childs 1992) . Thus, if hypophysectomy has not been complete and some suppressed but otherwise unaffected corticotropes remain in the sella turcica, their function is first restored by cessation of the glucocorticoid excess. The low cortisol levels after hypophysectomy will also stimulate release of hypophysiotropic hormones such as CRH and AVP and consequently the corticotropes may increase in number. The striking similarity with respect to the residual corticotropic response following hypophysiotropic stimulation in normal dogs (Meij et al. 1997a) and dogs with PDH (this study) suggests that this mechanism may cause remaining normal corticotropes to become functional again and subsequently increase in number by chronic stimulation.
A second or concurrent option is that residual corticotropic response may be due to the removal of hypothalamic inhibitory input to the residual cells. The existence of a hypothalamic corticotropin-release inhibiting factor has long been proposed on the basis of hypothalamo-pituitary disconnection studies in several species, including the dog (Egdahl 1960 , Halász et al. 1967 , Engler et al. 1990 , Redei et al. 1995 . These studies have consistently reported elevated basal levels of ACTH and glucocorticoids, and increases in anterior pituitary proopiomelanocortin (POMC) mRNA levels, suggesting that disconnection removes inhibitory influences, presumably of hypothalamic origin, from the corticotropic cell.
Thirdly, there is increasing evidence that local communication among cells of the anterior pituitary plays an important role in the regulation of ACTH secretion (Schwartz et al. 1989 , Schwartz 1990 ). Further investigation has led to the conclusion that paracrine communication among distinct fractions of corticotropes of the anterior pituitary regulates ACTH secretion ( Jia et al. 1992) . It was postulated that a paracrine factor profoundly inhibits CRH-stimulated ACTH secretion from a repressed fraction of corticotropes, a mechanism which functions to hold corticotropes in reserve ( Jia et al. 1992) . Thus it can be hypothesized that, as has been found in healthy dogs (Meij et al. 1997a) , after hypophysectomy in dogs with PDH, a critical intercell distance may be exceeded between dislodged pituitary cells in the sella turcica. The absence of the inhibitory effect of the postulated paracrine factor would allow the corticotropes among the pituitary cells and the reserve cells to become responsive to CRH. The latter mechanism may contribute to the gradual development of higher cortisol levels and a residual response to hypophysiotropic stimulation after hypophysectomy.
In the dog the dorsoventral axis of the hypophysis is orientated in a horizontal plane (Hullinger 1993) . Using the ventral transsphenoidal approach in the dog (Meij et al. 1997b) , the centroventral portion of the pars distalis is the first part of the hypophysis to be encountered. This portion and the rostral portion of the pars distalis contain high concentrations of corticotropic and lactotropic cells (El Etreby & Fath El Bab 1977 , El Etreby & Dubois 1980 . From a surgical anatomical viewpoint the rostral portion of the pars distalis is considered to be the region which is most difficult to remove, which seems to be consistent with our finding that after surgery basal ACTH levels were correlated with basal PRL values. Corticotropic cells are much less frequent in the pars tuberalis than in the pars distalis of the adenohypophysis in the dog (El Etreby & Dubois 1980 , Halmi & Krieger 1983 and the presence of remnants of pars tuberalis after hypophysectomy would therefore not provide an adequate explanation for a significant residual corticotropic response. Moreover, it was shown previously that no remnants of pars tuberalis were observed on the ventral hypothalamus following hypophysectomy in normal dogs (Meij et al. 1997a,b) . The origin of the corticotropic cells responsible for the residual corticotropic response is therefore most likely the rostral portion of the pars distalis.
The pars intermedia of the dog is cytologically heterogenous. The predominant A cells are typical pars intermedia cells: they stain immunocytochemically for -MSH and less strongly for ACTH. The considerably less common B cells are generally dispersed among the A cells and are immunocytochemically similar to the corticotropic cells of the pars distalis, i.e. they stain intensely for ACTH but not at all for -MSH (Halmi & Krieger 1983) . The pars intermedia in the dog is under tonic dopaminergic inhibition (Zerbe et al. 1993) . Thus, corticotropes and melanotropes in isolated pars intermedia fragments in the sella after hypophysectomy are devoid of the dopaminergic inhibitory influences, and this will favor secretory activity and possibly proliferation. In addition, there is increasing evidence that the corticotropic and melanotropic cells are differentially regulated, -MSH release being almost permanently suppressed by dopaminergic influences and the release of ACTH from the B cells also being influenced by CRH (Kooistra et al. 1997) .
Canine PDH is usually caused by pars distalis adenomas but the excess of POMC-derived peptides may also originate from neoplastic transformation of the pars intermedia, resulting in high -MSH levels (Peterson et al. 1986 , Orth et al. 1988 , Rijnberk et al. 1988b as was found in 7 of 39 dogs. In these dogs hypophysectomy caused -MSH concentration to decline to the basal levels found in normal dogs. This return to basal, fully suppressed, -MSH values indicates complete removal of these pituitary adenomas that most likely originated from the pars intermedia. In the 32 dogs in which -MSH concentrations were not elevated, there was no change after hypophysectomy, indicating that before hypophysectomy there was maximal inhibition of -MSH release.
From this study and a previous study in healthy dogs it can be concluded that among the adenohypophyseal cells present after hypophysectomy in small pituitary sellar islets, the corticotropes have a distinct behavior. Much more so than the other cell types, the unaffected corticotropes tend to remain functional, or a repressed reserve fraction of corticotropes may become functional. This may be due to the removal of the hypothalamic influence of a postulated corticotropin-release inhibiting factor or a diminished inhibitory influence of a postulated paracrine factor. In this sellar environment the corticotropes may maintain normocorticism, but may also lead to mild recurrence of hyperadrenocorticism after relatively long periods of remission.
